• Explore /
  • Poster
  • / Using T stage to predict outcomes of adjuvant oxaliplatin (OX)-based chemotherapy (CT) in stage III colon cancer (CC): An ACCENT pooled analysis.

Using T stage to predict outcomes of adjuvant oxaliplatin (OX)-based chemotherapy (CT) in stage III colon cancer (CC): An ACCENT pooled analysis.

Abstract Poster

Authors

null

Romain Cohen

Sorbonne University, Department of Medical Oncology, Saint-Antoine Hospital, AP-HP, Paris, France

Romain Cohen , Morteza Raeisi , Greg Yothers , Hans-Joachim Schmoll , Daniel G. Haller , Jean-Baptiste Bachet , Benoist Chibaudel , Norman Wolmark , Takayuki Yoshino , Richard M. Goldberg , Rachel Kerr , Sara Lonardi , Thomas J. George , Einat Shacham Shmueli , Lama Sharara , Thierry Andre , Qian Shi , Aimery De Gramont

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Colorectal and Anal

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Colorectal Cancer - Neo-Adjuvant/Adjuvant

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 3606)

DOI

10.1200/JCO.2022.40.16_suppl.3606

Abstract #

3606

Poster Bd #

400

Abstract Disclosures

Similar Posters

Poster

2017 Gastrointestinal Cancers Symposium

Survival impact of CAPOX versus FOLFOX in the adjuvant treatment of stage III colon cancer.

Survival impact of CAPOX versus FOLFOX in the adjuvant treatment of stage III colon cancer.

First Author: Jonathan M. Loree

First Author: Jemma Megan Boyle

First Author: Suganija Lakkunarajah

First Author: Takuya Miura